Status:
COMPLETED
Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia
Lead Sponsor:
Eastern Cooperative Oncology Group
Conditions:
Adult Patients (Over 55) With Acute Non-Lymphocytic Leukemia
Eligibility:
All Genders
56+ years
Phase:
PHASE3
Brief Summary
Phase III Study of Priming with Granulocyte-Macrophage Colony Stimulating Factor (rhu-GM-CSF) and ofThree Induction Regimens in Adult Patients (Over 55) with Acute Non-Lymphocytic Leukemia
Eligibility Criteria
Inclusion
- All patients with acute non-lymphocytic leukemia are eligible for the study.
Exclusion
- N/A
Key Trial Info
Start Date :
May 21 1993
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2002
Estimated Enrollment :
362 Patients enrolled
Trial Details
Trial ID
NCT04446052
Start Date
May 21 1993
End Date
July 10 2002
Last Update
June 22 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.